(0.18%) 5 140.50 points
(0.09%) 38 477 points
(0.29%) 17 897 points
(-0.42%) $83.50
(1.72%) $1.956
(0.15%) $2 350.80
(0.36%) $27.64
(1.32%) $934.30
(-0.02%) $0.934
(-0.13%) $11.01
(-0.15%) $0.799
(1.30%) $93.07
Live Chart Being Loaded With Signals
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions...
Stats | |
---|---|
今日成交量 | 19 742.00 |
平均成交量 | 81 625.00 |
市值 | 17.89M |
EPS | $0 ( 2024-02-12 ) |
下一个收益日期 | ( $-0.780 ) 2024-05-13 |
Last Dividend | $0.0450 ( 2018-06-01 ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0300 |
ATR14 | $0.0330 (0.48%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-06 | Banks Jerel A. | Buy | 466 554 | Options (right to buy) |
2024-03-06 | Boston Megan | Buy | 200 004 | Options (right to buy) |
2023-12-06 | Smith Edward F | Buy | 35 000 | Options (right to buy) |
2023-12-06 | Francis Peter | Buy | 35 000 | Options (right to buy) |
2023-12-06 | Buchi J Kevin | Buy | 35 000 | Options (right to buy) |
INSIDER POWER |
---|
100.00 |
Last 38 transactions |
Buy: 2 361 696 | Sell: 57 465 |
音量 相关性
Benitec Biopharma Inc 相关性
10 最负相关 | |
---|---|
MBCN | -0.811 |
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Benitec Biopharma Inc 相关性 - 货币/商品
Benitec Biopharma Inc 财务报表
Annual | 2023 |
营收: | $75 000.00 |
毛利润: | $-306 000 (-408.00 %) |
EPS: | $-14.12 |
FY | 2023 |
营收: | $75 000.00 |
毛利润: | $-306 000 (-408.00 %) |
EPS: | $-14.12 |
FY | 2022 |
营收: | $73 000.00 |
毛利润: | $64 000.00 (87.67 %) |
EPS: | $-38.62 |
FY | 2021 |
营收: | $59 000.00 |
毛利润: | $-64 000.00 (-108.47 %) |
EPS: | $-3.23 |
Financial Reports:
No articles found.
Benitec Biopharma Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.0450 | 2018-06-01 |
Last Dividend | $0.0450 | 2018-06-01 |
Next Dividend | $0 | N/A |
Payout Date | 2018-06-08 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.0450 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.01 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2018 | $0.0450 | 0.01% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -358.57 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -1.024 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -2.05 | 1.500 | -10.00 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 3.62 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.55 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 3.55 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0198 | -1.500 | 9.67 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -1 446.13 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -7.01 | 2.00 | -2.34 | -4.67 | [0 - 30] |
freeCashFlowPerShareTTM | -7.01 | 2.00 | -3.51 | -7.01 | [0 - 20] |
debtEquityRatioTTM | 0.0273 | -1.500 | 9.89 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.820 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -355.61 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -42.71 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.00286 | 0.800 | -3.31 | -2.65 | [0.5 - 2] |
Total Score | -1.934 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.813 | 1.000 | -0.183 | 0 | [1 - 100] |
returnOnEquityTTM | -2.05 | 2.50 | -10.00 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -7.01 | 2.00 | -2.34 | -7.01 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -7.01 | 2.00 | -2.34 | -4.67 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.00690 | 1.500 | -3.29 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -296.16 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -3.45 |
Benitec Biopharma Inc
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。